Bio-Techne Corp (NASDAQ:TECH) Shares Drop 7.7% on Q1 Earnings and Revenue Miss

Bio-Techne Corp (NASDAQ:TECH) reported financial results for the first quarter of fiscal year 2026, revealing a performance that fell short of analyst expectations on key financial metrics. The market's immediate reaction has been notably negative, with the stock trading significantly lower in pre-market activity following the earnings release.

First Quarter Fiscal 2026 Performance Versus Estimates

The company's reported figures for the quarter ended September 30, 2025, missed the mark set by Wall Street analysts. The primary points of concern are the top and bottom-line results, which both came in below consensus forecasts.

• Revenue: The company reported revenue of $286.6 million. This fell short of the analyst estimate of $297.1 million.
• Earnings Per Share (EPS): The non-GAAP EPS was reported at $0.42. This was below the estimated $0.43 per share.

This dual miss on both revenue and earnings represents a clear deviation from market expectations and appears to be the primary driver behind the negative investor sentiment observed in pre-market trading.

Market Reaction and Price Action

The financial markets have responded decisively to the earnings report. The stock is currently indicating a sharp decline at the open, reflecting investor disappointment with the quarterly results.

• Pre-Market Performance: TECH is down approximately 7.7% in pre-market trading.
• Recent Trend Context: Prior to the earnings release, the stock had been relatively stable, with a slight gain of about 3.2% over the past month. The pre-market drop effectively erases recent gains and places the stock under significant selling pressure.

This negative price action suggests that investors are reassessing the company's near-term growth trajectory and profitability in light of the Q1 figures.

Press Release Summary and Forward-Looking Context

The press release announced the company's financial results for the first quarter of fiscal 2026. While the detailed report outlines the operational performance, the core takeaway for investors is the earnings and revenue miss. The release also contained an announcement from the Board of Directors regarding a quarterly cash dividend of $0.08 per share, a separate corporate action that maintains the company's shareholder return policy but does not offset the concerns from the earnings shortfall.

Looking ahead, analyst estimates for the upcoming quarter and full fiscal year provide a benchmark for future performance. For the second quarter of fiscal 2026, analysts are projecting revenue of approximately $304.5 million and EPS of around $0.47. For the full 2026 fiscal year, the consensus sales estimate stands at $1.27 billion. The company's ability to meet or exceed these future estimates will be critical in rebuilding investor confidence following the Q1 disappointment.

For a detailed breakdown of historical earnings, future estimates, and analyst revisions, you can review the data here.

---

Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. The content presented is based on data believed to be reliable, but its accuracy cannot be guaranteed. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.